Oncotarget is a research journal publication, and it is open to access for the medics who feel they have some contributing information. It covers deep research in oncology. This journal was established in 2010 and published by impact journals. Mikhail Blagosklonny and Andrei V. Gudkov are the head editors. They make their publication on a weekly basis though when there is a special request it can be printed. Check the journal at SCImago Journal & Country Rank.
Vision and Mission
The overarching purpose of Oncotarget is to have the scientific findings go viral and consequently maximize the impact of research through insightful review.Allowing the exceptional discoveries to get shared quickly saves billions of dollars and countless lives. The ultimate goal of Oncotarget is a life without diseases especially the terrible one called cancer.
Oncotarget has made the focus of all its energy to be on all cancers. The achieves page on the site shows some rarely known of therapy and treatment employed to improve management of patients who have cancer. The journal also has a focus on the impact of management programs. The journal in compromises the new therapeutic ways and protocols of the patient perspective like adherence, satisfaction, and quality of life. Oncotarget researchers get drawn from vast backgrounds. The one thing uniting them is their passion for cancer research sharing. And, that’s what this site provides them with.
The site continues to draw both admiration and cynicism from the public. Some people claim that it is a brilliant innovation which ought to help ease the collaborative efforts of researchers working on the same potential cancer therapy but who are Worlds apart. Some naysayers, however, like to argue that there is a risk of their research being stolen and used without their permissions. But, then again, and in defense of the Oncotarget, these critics are wrong since there’s a free license agreement to all who agree to post on the portal.
Oncotarget is the journal that is contributing positive change in the world of health care. Improving on the research and coming up with better ways to cure diseases and having a world free of disease at the end. Follow Oncotarget journal on Twitter.